Browse by Journal Title

2020

Clinical outcome in patients with carcinoma of the esophagogastric junction treated with neoadjuvant radiochemotherapy or perioperative chemotherapy: a two-enter retrospective analysis.
Wundsam, H.V., Doleschal, B., Prommer, R., Venhoda, C., Schmitt, C., Petzer, A., Metz-Gercek, S. and Rumpold, H.
Oncology 98 (10): 706-713. October 2020

2003

Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.
Gretschel, S., Haensch, W., Schlag, P.M. and Kemmner, W.
Oncology 65 (2): 139-145. 2003

2001

Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
Baldus, S.E., Zirbes, T., Glossmann, J., Fromm, S., Hanisch, F.G., Moenig, S.P., Schroeder, W., Schneider, P.M., Flucke, U., Karsten, U., Thiele, J., Hoelscher, A.H. and Dienes, H.P.
Oncology 61 (2): 147-155. 1 January 2001

2000

Weekly 24-Hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer.
Kretzschmar, A., Reichardt, P., Thuss-Patience, P.C., Hohenberger, P., Benter, T., Doerken, B. and Koehne, C.H.
Oncology 59 (1): 14-17. June 2000

Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIO.
Szelenyi, H., Hohenberger, P., Lochs, H., Haboubi, N., Berdel, W.E., Thiel, E. and Kreuser, E.D.
Oncology 58 : 273-279. 1 May 2000

1998

Is continuous 24-Hour Infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
Hartmann, J.T., Koehne, C.H., Schmoll, H.J., Daikeler, T., Kanz, L. and Bokemeyer, C.
Oncology 55 : 320-325. 1 January 1998

Clinical management and current research in isolated limb perfusion for sarcoma melanoma.
Hohenberger, P. and Kettelhack, C.
Oncology 55 : 89-102. 1 January 1998

A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases.
Lorenz, M., Staib-Sebler, E., Gog, C., Petrowsky, H., Koehne, C.H. and Encke, A.
Oncology 55 : 53-58. 1 January 1998

1997

Phase II evaluation of 5-fluorouracil plus folinic acid and alpha2b-interferon in metastatic colorectal cancer.
Koehne, C.H., Wilke, H., Hiddemann, W., Bokemeyer, C., Lohrmann, H.P., Bodenstein, H., Preiss, J., Rauschecker, H., Hill, H., Kaeufer, C., Fischer, J.T., Ohl, U., Urbanitz, D., Balleisen, L. and Schmoll, H.J.
Oncology 54 : 96-101. 1 January 1997

1992

Homotypic aggregation and terminal glycosylation of cells from dissociated human colorectal tumor tissue.
Kemmner, W., Schlag, P.M., Moeller, P. and Brossmer, R.
Oncology 49 : 63-67. 1 January 1992